Cargando…
Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis
BACKGROUND: There remains uncertainty about the optimum timing of antiretroviral therapy (ART) initiation in HIV‐positive people with cryptococcal meningitis. This uncertainty is the result of conflicting data on the mortality risk and occurrence of immune reconstitution inflammatory syndrome (IRIS)...
Autores principales: | Eshun‐Wilson, Ingrid, Okwen, Mbah P, Richardson, Marty, Bicanic, Tihana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513637/ https://www.ncbi.nlm.nih.gov/pubmed/30039850 http://dx.doi.org/10.1002/14651858.CD009012.pub3 |
Ejemplares similares
-
Combination Therapy for HIV-Associated Cryptococcal Meningitis—A Success Story
por: Hurt, William J., et al.
Publicado: (2021) -
Treatment for HIV‐associated cryptococcal meningitis
por: Tenforde, Mark W, et al.
Publicado: (2018) -
Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people
por: Awotiwon, Ajibola A, et al.
Publicado: (2018) -
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
por: Bicanic, Tihana, et al.
Publicado: (2015) -
Cerebrospinal Fluid Cytokine Profiles Predict Risk of Early Mortality and Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis
por: Jarvis, Joseph N., et al.
Publicado: (2015)